Moreover, CD8+ T cell function was found to be inhibited by CD38-mediated adenosine production, and anti-PD-L1 and CD38 combination therapy synergistically inhibited the growth of murine lung adenocarcinoma tumors[114]. This evidence concerns the gene CD38 and lung adenocarcinoma.